Nissen fundoplication

The Inner Circle Acknowledges, Abdelhai Abdelqader as a Top Pinnacle Professional

Retrieved on: 
Monday, January 22, 2024

SARASOTA, Fla., Jan. 22, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Abdelhai Abdelqader is acknowledged as a Top Pinnacle Professional for his contributions to the field of Gastroenterology.

Key Points: 
  • SARASOTA, Fla., Jan. 22, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Abdelhai Abdelqader is acknowledged as a Top Pinnacle Professional for his contributions to the field of Gastroenterology.
  • Dr. Abdelqader pursued higher education at Loyola University where he earned a Bachelor of Science degree.
  • Dr. Abdelqader is considered an expert in colorectal and esophageal cancer screening, as well as advanced endoscopy and surgical endoscopy.
  • Dr. Abdelhai Abdelqader is a practicing gastroenterologist based in Sarasota, FL.

Implantica publishes Interim Report January - September 2023 (Q3)

Retrieved on: 
Wednesday, November 22, 2023

The Interventional Procedures Advisory Committee (IPAC) has now started its review of the safety and efficacy of RefluxStop™.

Key Points: 
  • The Interventional Procedures Advisory Committee (IPAC) has now started its review of the safety and efficacy of RefluxStop™.
  • The IPAC review process is a key step for NHS hospitals to adopt our technology with strong international influence.
  • Implantica will hold a teleconference on 22 November 2023 at 15:00 (CET) with Peter Forsell (CEO), Andreas Öhrnberg (CFO), and Nicole Pehrsson (Chief Corporate Affairs Officer).
  • The information was submitted for publication, through the agency of the contact person set out above, at 2023-11-22 08:00 CET.

Aplos Medical Achieves a Major Milestone in GERD Treatment with Omega PF™

Retrieved on: 
Friday, November 3, 2023

EDEN PRAIRIE, Minn., Nov. 3, 2023 /PRNewswire/ -- Aplos Medical (formerly CT Resources), developer of the next generation Gastroesophageal Reflux Disease (GERD) treatment, proudly announces the successful first implantation of its revolutionary Omega PF™ device.

Key Points: 
  • EDEN PRAIRIE, Minn., Nov. 3, 2023 /PRNewswire/ -- Aplos Medical (formerly CT Resources), developer of the next generation Gastroesophageal Reflux Disease (GERD) treatment, proudly announces the successful first implantation of its revolutionary Omega PF™ device.
  • The Omega PF™ device heralds a paradigm shift in GERD treatment.
  • "We are delighted by this monumental achievement, performed by Dr. Buckley and his team," Aplos Medical President and CEO Dr. Claude Tihon said.
  • "The simple Omega PF™ device is designed to mitigate common issues seen with current GERD treatments.

The Surgical Clinic in Nashville, Tennessee, Offers the Minimally Invasive TIF® 2.0 Procedure for Patients with GERD

Retrieved on: 
Wednesday, June 14, 2023

Dr. Willie Melvin at The Surgical Clinic in Nashville, Tennessee, offers the Transoral Incisionless Fundoplication (TIF®) procedure for patients with gastroesophageal reflux disease (GERD).

Key Points: 
  • Dr. Willie Melvin at The Surgical Clinic in Nashville, Tennessee, offers the Transoral Incisionless Fundoplication (TIF®) procedure for patients with gastroesophageal reflux disease (GERD).
  • The TIF® 2.0 procedure is a minimally invasive, incisionless surgical solution for patients suffering from GERD and has been shown to improve patient outcomes and provide symptom relief.
  • Symptoms can be debilitating for those affected and can cause chronic heartburn, asthma, cough, regurgitation, and hoarse voice or chest pain.
  • “As an avid outdoors person, it was difficult not having enough energy due to my GERD symptoms interfering with my sleep.

Implantica publishes Interim Report January - March 2023 (Q1)

Retrieved on: 
Friday, May 12, 2023

VADUZ, Liechtenstein, May 12, 2023 /PRNewswire/ --

Key Points: 
  • The first RefluxStop™ surgeries have been performed in Spain as we continue to prepare for the public tender process.
  • Another major German Reflux Center, Klinikum Aschaffenburg, completed first RefluxStop cases and also signed up for the Registry study.
  • Implantica has been selected as one of 50 Admired Companies to Watch 2023 by CIO Bulletin.
  • Implantica will hold a teleconference with Peter Forsell (CEO), Andreas Öhrnberg (CFO) and Nicole Pehrsson (Chief Corporate Affairs Officer & Investor Relations).

Implantica publishes Year-end Report, January - December 2022 (Q4)

Retrieved on: 
Friday, February 17, 2023

Implantica receives Global Health & Pharma's Award; Most Innovative MedTech Company- Central Europe for 2022 based on a serious due diligence by GHP, identifying the high innovation level of Implantica.

Key Points: 
  • Implantica receives Global Health & Pharma's Award; Most Innovative MedTech Company- Central Europe for 2022 based on a serious due diligence by GHP, identifying the high innovation level of Implantica.
  • Implantica attended the European Foregut Society (EFS) Conference in Belgrade, Serbia where the positive clinical outcomes of RefluxStop were presented by Dr. med.
  • Implantica presented RefluxStop's health economic impact at one of the biggest Payer conferences, ISPOR, the International Society for Pharmacoeconomics and Outcomes Research Conference in Vienna, Austria.
  • Implantica will hold a teleconference with Peter Forsell (CEO), Andreas Öhrnberg (CFO) and Nicole Pehrsson (Chief Corporate Affairs Officer).

EndoGastric Solutions, Inc.® Develops Reflux-Friendly Cookbook to Promote GERD Awareness Week

Retrieved on: 
Monday, November 21, 2022

EndoGastric Solutions, Inc. today announced the companies national campaign, GERD Gourmet; Recipes for Reflux, supporting GERD Awareness Week, November 20th-26th.

Key Points: 
  • EndoGastric Solutions, Inc. today announced the companies national campaign, GERD Gourmet; Recipes for Reflux, supporting GERD Awareness Week, November 20th-26th.
  • The International Federation for Gastrointestinal Diseases (IFFGD) designated Gerd Awareness Week as a time for encouraging individuals experiencing GERD symptoms to consult their physician and seek out information and support regarding the condition.
  • The first line of treatment for patients with GERD is often to make lifestyle changes, including diet and scheduled eating times.
  • GERD Awareness Week is the ideal time to remind patients that they should take their GERD symptoms seriously.

Implantica publishes Interim Report Q3 2022

Retrieved on: 
Tuesday, November 15, 2022

Implantica initiated a therapy awareness project to enhance the patient, physician and caregiver's awareness about gastroesophageal reflux disease (GERD) and anti-reflux surgery.

Key Points: 
  • Implantica initiated a therapy awareness project to enhance the patient, physician and caregiver's awareness about gastroesophageal reflux disease (GERD) and anti-reflux surgery.
  • Implantica receives Global Health & Pharma's Most Innovative MedTech Company Central Europe Award for 2022 based on a serious due diligence by GHP, identifying the high innovation level of Implantica.
  • Implantica attended the European Foregut Society (EFS) Conference in Belgrade, Serbia where the good clinical outcomes of RefluxStop were presented by Dr. med.
  • Implantica will hold a telephone conference on November 15 at 15:00 CET.

Wisconsin Surgical Clinic Welcomes Renowned Reflux Specialist to Team

Retrieved on: 
Wednesday, October 9, 2019

At FVSA , he will continue to pioneer the way in performing the most advanced surgeries to treat gastroesophageal reflux disease (GERD) in Northeast Wisconsin, including transoral incisionless fundoplication (TIF) and magnetic sphincter augmentation.

Key Points: 
  • At FVSA , he will continue to pioneer the way in performing the most advanced surgeries to treat gastroesophageal reflux disease (GERD) in Northeast Wisconsin, including transoral incisionless fundoplication (TIF) and magnetic sphincter augmentation.
  • Dr. Janu's latest role involved heading up an area reflux center and his experience includes ongoing participation in national clinical research trials for both endoscopic and laparoscopic reflux treatment options.
  • He is a Fellow of the American College of Surgeons and a member of the Wisconsin Surgical Society.
  • In growing its practice, FVSA has also welcomed three additional providers in the last few months:
    Fox Valley Surgical Associates (FVSA) has been serving patients in Northeast Wisconsin since 1970.

EndoGastric Solutions’ TIF 2.0 Procedure Highlighted in Multiple Sessions at DDW 2019

Retrieved on: 
Thursday, May 9, 2019

EndoGastric Solutions today announced that new data on the Transoral Incisionless Fundoplication (TIF 2.0) procedure will be presented during multiple sessions at Digestive Disease Week (DDW) 2019 .

Key Points: 
  • EndoGastric Solutions today announced that new data on the Transoral Incisionless Fundoplication (TIF 2.0) procedure will be presented during multiple sessions at Digestive Disease Week (DDW) 2019 .
  • We are pleased to have multiple opportunities to share incremental clinical findings underscoring the efficacy of TIF 2.0 and the high level of patient satisfaction for the TIF 2.0 procedure, said Skip Baldino, President and CEO of EndoGastric Solutions.
  • Mo1229: Transoral Incisionless Fundoplication (TIF) To The Rescue: Is TIF The Answer To Post-POEM Gerd?
  • EndoGastric Solutions is sponsoring a symposium at DDW 2019 titled Shaping the Future of GERD from 11:30 a.m. to 12:05 p.m. on Sunday, May 19, in the DDW Product Theater 1.